{"id":11643,"date":"2026-10-28T13:48:51","date_gmt":"2026-10-28T10:48:51","guid":{"rendered":"https:\/\/www.ortaakarsu.net\/?ism_drug=ethosuximide-etosuksimid"},"modified":"2026-10-28T13:48:51","modified_gmt":"2026-10-28T10:48:51","slug":"ethosuximide-etosuksimid","status":"publish","type":"ism_drug","link":"https:\/\/www.ortaakarsu.net\/?ism_drug=ethosuximide-etosuksimid","title":{"rendered":"Ethosuximide (Etos\u00fcksimid)"},"content":{"rendered":"<p><strong>Ethosuximide (Etos\u00fcksimid)<\/strong>, Etos\u00fcksimid etken maddesinin uluslararas\u0131 ad\u0131 \u00fczerinden haz\u0131rlanm\u0131\u015f bilgi sayfas\u0131d\u0131r.<\/p>\n<p><strong>Uygulama kapsam\u0131:<\/strong> A\u011f\u0131zdan; incelenen kaps\u00fcl yemek s\u0131ras\u0131nda veya sonras\u0131nda bir miktar s\u0131v\u0131yla al\u0131nabilir. Doz ve de\u011fi\u015fiklikler klinik yan\u0131t ile gerekti\u011finde kan d\u00fczeyine g\u00f6re hekimce belirlenir. Ba\u015fka n\u00f6bet ilac\u0131na ge\u00e7i\u015f veya kesilme kademeli planlan\u0131r. Farkl\u0131 g\u00fc\u00e7 ve farmas\u00f6tik formlar\u0131n birbirinin yerine kullan\u0131labilece\u011fi varsay\u0131lmamal\u0131d\u0131r.<\/p>\n<h2>T\u00fcrkiye\u2019de yurt d\u0131\u015f\u0131ndan temin kayd\u0131<\/h2>\n<p><a href=\"https:\/\/www.teb.org.tr\/docs\/3aac322e-7bec-4df1-a37f-0dd1757bed11\/yurtdisi-aktif-ilac-listesi\" rel=\"noopener\">TEB\u2019in 2 Ekim 2026 tarihli \u00fcr\u00fcn listesinde<\/a> bu etken maddeyi i\u00e7eren \u00fcr\u00fcn kay\u0131tlar\u0131 do\u011fruland\u0131: ETHOSUXIMIDE BROWN &amp; BURK 250 MG\/5 ML ORAL SOLUTION; ETOSUXIMIDA FAES 250 MG 30 CAPSULES DURAS; PETNIDAN SAFT 50MG\/ML 250 ML ve di\u011fer kay\u0131tl\u0131 \u00fcr\u00fcnler. <a href=\"https:\/\/www.titck.gov.tr\/dinamikmodul\/126\" rel=\"noopener\">T\u0130TCK\u2019nin 28 Eyl\u00fcl 2026 tarihli etken madde listesi<\/a> ayr\u0131ca kontrol edildi. Temin ko\u015fullar\u0131 hastaya, re\u00e7eteye, endikasyona ve gerekli onaylara g\u00f6re de\u011fi\u015febilir; listede yer almak g\u00fcncel stok veya geri \u00f6deme garantisi de\u011fildir. Klinik kullan\u0131m alan\u0131 a\u015fa\u011f\u0131daki \u00fcr\u00fcn belgesine g\u00f6re a\u00e7\u0131klan\u0131r; temin listesindeki tan\u0131 ko\u015fullar\u0131 tek ba\u015f\u0131na yeni bir klinik endikasyon olu\u015fturmaz.<\/p>\n<h2>Kaynaklar<\/h2>\n<ul>\n<li><a href=\"https:\/\/www.medicines.org.uk\/emc\/product\/14872\/smpc\" rel=\"noopener\">Epesri (ethosuximide) UK SmPC<\/a> (Epesri UK SmPC; metin 24.03.2026; emc 15.05.2026)<\/li>\n<li><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38606683\/\" rel=\"noopener\">Ethosuximide lowers lamotrigine serum concentrations: Evidence for a clinically relevant interaction<\/a> \u2014 Hagemann A; Herting A; Klimpel D; Bien CG; Polster T; Epilepsia; 2024; DOI: 10.1111\/epi.17952<\/li>\n<\/ul>\n<p>Kaynak kontrol\u00fc: <time datetime=\"2026-10-28\">28 Ekim 2026<\/time>. Bu tarih, bir hekim veya eczac\u0131 taraf\u0131ndan klinik inceleme yap\u0131ld\u0131\u011f\u0131 anlam\u0131na gelmez. Ki\u015fisel tedavi plan\u0131 i\u00e7in kullan\u0131lan \u00fcr\u00fcn\u00fcn g\u00fcncel talimat\u0131 ve sa\u011fl\u0131k uzman\u0131n\u0131n de\u011ferlendirmesi esas al\u0131n\u0131r.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ethosuximide (Etos\u00fcksimid), Etos\u00fcksimid etken maddesinin uluslararas\u0131 ad\u0131 \u00fczerinden haz\u0131rlanm\u0131\u015f bilgi  [&#8230;]<\/p>\n","protected":false},"featured_media":0,"template":"","ism_etken_madde":[1272],"class_list":["post-11643","ism_drug","type-ism_drug","status-publish","hentry","ism_etken_madde-etosuksimid"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/ism_drug\/11643","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/ism_drug"}],"about":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/types\/ism_drug"}],"version-history":[{"count":1,"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/ism_drug\/11643\/revisions"}],"predecessor-version":[{"id":11644,"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=\/wp\/v2\/ism_drug\/11643\/revisions\/11644"}],"wp:attachment":[{"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11643"}],"wp:term":[{"taxonomy":"ism_etken_madde","embeddable":true,"href":"https:\/\/www.ortaakarsu.net\/index.php?rest_route=%2Fwp%2Fv2%2Fism_etken_madde&post=11643"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}